GVK Biosciences under the scanner of European Medicines Agency

Inspection by French regulatory was conducted from May 19-23rd in the clinical facility and as per the statement of a GVK company official the necessary clarifications have been submitted to the French authorities.
A meeting was held between GVK bio and European authorities where GVK Bio presented their data and explained how the processes are optimized internally but resolution to the issues raised is still awaited.